AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PIPEHAWK PLC

Regulatory Filings Jan 18, 2019

7847_rns_2019-01-18_30dafc3d-4c27-4de8-8128-5262caf0c1cd.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5314N

PipeHawk PLC

18 January 2019

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

18 January 2019

PipeHawk plc

("PipeHawk" or the "Company")

Major contract award by Penso (UK) Ltd

The Company is pleased to announce that its subsidiary, QM Systems, has been awarded a partnership contract by Penso UK Ltd to provide a fully automated production facility for the manufacture of a new carbon fibre product to be installed at Penso UK Ltd's facility in Coventry. The contract value is approximately £2.6 million and is due for completion in October 2019.

Gordon Watt, Chairman of PipeHawk commented, "This is great news and marks the continued development of QM Systems' innovation technology into new and exciting industries. We are very proud to be selected as Penso UK Ltd's partner for this new and exciting journey in both companies' futures"

Enquiries:

PipeHawk Plc

Gordon Watt (Chairman)
Tel. No. 01252 338 959
Allenby Capital Limited (Nomad and Broker)

David Worlidge / Asha Chotai
Tel. No. 020 3328 5656

Notes to Editors

For further information on the Company and its subsidiaries, please visit: www.pipehawk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

CNTUWOARKAAAAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.